ALDH1A2 and acute lymphoblastic leukemia: Earlier studies also showed that ALDH1a2 was amplified in nearly all T-ALL patients, including TAL1-negative patients, suggesting a critical need for ALDH1a2 activity (Palomero et al., 2006).